Vuity has been available for more than a year, in which time we have learned a lot about this modality for treating presbyopia and honed our methods for selecting, screening and educating patients.
Here are three ways my approach has evolved.
Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%, Allergan) is indicated for any presbyopic patient who has no disqualifying anatomical problems. It works exceptionally well for latent hyperopes in their late 30s and 40s who are just starting to wear readers, making this group a good place to start using Vuity. I have also learned to recommend it